AKT1 and hepatocellular carcinoma: Delivery of miR-122 into HepG2 cells followed by its negative regulation expression; aids the sensitivity of HCC cells to chemotherapeutic agents. miR-32-5p facilitates the activation of PI3K/Akt pathway thus providing MDR to sensitive cells.